← Back to Search

EHR-based "nudge" interventions for Inappropriate Medications

N/A
Waitlist Available
Led By Jashvant Poeran, MD, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post-discharge regarding hospitalization during which a high-risk drug was prescribed
Awards & highlights

Study Summary

This trial will study whether modifying the default dose for high-risk drugs when prescribed electronically to hospitalized patients aged ≥65 years impacts prescribing behavior.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post-discharge regarding hospitalization during which a high-risk drug was prescribed
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post-discharge regarding hospitalization during which a high-risk drug was prescribed for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prescription rate of modified default dose for eight high-risk drugs
Secondary outcome measures
Cost of hospital stay
Drug-specific prescription rate
Length of hospital stay
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The first option a prescriber sees when prescribing any of eight high-risk drugs for elderly hospitalized patients will be modified; the first frequency option a prescriber sees will be modified as well. Providers retain the ability to prescribe any dose or frequency.
Group II: ControlActive Control1 Intervention
No change in default dose or frequency selected for the eight targeted drugs
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EHR-based "nudge" interventions
2022
N/A
~8640

Find a Location

Who is running the clinical trial?

NYC Health + HospitalsUNKNOWN
2 Previous Clinical Trials
150,052 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
515,646 Total Patients Enrolled
Jashvant Poeran, MD, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on participants in this research endeavor?

"Yes, the information shared on clinicaltrials.gov affirms that recruitment for this research is ongoing. The trial first appeared online on February 16th 2022 and was most recently updated in April 6th 2022; it requires 8640 participants from 1 medical centre."

Answered by AI

Are researchers still signing up participants for this study?

"The clinical trial database confirms that recruitment is ongoing for this medical trial. It was initially posted on February 16th 2022 and the last edit to it occured on April 6th, 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System
Jashvant Poeran 2022. "An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05218343.
~2728 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top